Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ascendis Pharma A/S

174.96
-1.5300-0.87%
Post-market: 174.960.00000.00%17:23 EDT
Volume:387.28K
Turnover:67.87M
Market Cap:10.59B
PE:-27.80
High:177.18
Open:176.42
Low:173.78
Close:176.49
Loading ...

Ascendis Pharma Is Maintained at Buy by Citigroup

Dow Jones
·
Yesterday

Ascendis Pharma price target raised to $243 from $213 at Citi

TIPRANKS
·
11 Jul

Ascendis Pharma (ASND) Gets a Buy from UBS

TIPRANKS
·
09 Jul

Ascendis Pharma Coverage Assumed by Morgan Stanley at Overweight

Dow Jones
·
04 Jul

Visen Pharmaceuticals Conducted Annual General Meeting

Reuters
·
27 Jun

UBS Keeps Their Buy Rating on Ascendis Pharma (ASND)

TIPRANKS
·
26 Jun

European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading

MT Newswires Live
·
25 Jun

Summit Therapeutics Inc. Secures Sub-Sublease Agreement for New Office Space in Palo Alto

Reuters
·
21 Jun

Visen Pharmaceuticals Secures New Supply Agreement with Ascendis Europe for Drug Packages and Auto-Injectors

Reuters
·
12 Jun

Ascendis Pharma Set to Exceed Q2 Expectations, RBC Says

MT Newswires Live
·
11 Jun

RBC Capital Keeps Their Buy Rating on Ascendis Pharma (ASND)

TIPRANKS
·
10 Jun

Ascendis Pharma a/S : Jefferies Raises Target Price to $233.00 From $229.00

THOMSON REUTERS
·
10 Jun

Ascendis Pharma Is Maintained at Buy by B of A Securities

Dow Jones
·
10 Jun

Ascendis Pharma price target raised to $216 from $201 at BofA

TIPRANKS
·
09 Jun

Ascendis Pharma A/S Presents Interim Results from COACH Trial on Achondroplasia Treatment

Reuters
·
09 Jun

Ascendis Pharma announces interim analysis results from COACH trial

TIPRANKS
·
09 Jun

Ascendis Pharma Is Maintained at Buy by B of A Securities

Dow Jones
·
03 Jun

Ascendis Pharma a/S : Bofa Global Research Raises Price Objective to $201 From $196

THOMSON REUTERS
·
03 Jun

Teijin Limited Announces Phase III Clinical Trial Launch for Orphan Drug Navepegritide in Japan

Reuters
·
03 Jun

Bank of America Securities Remains a Buy on Ascendis Pharma (ASND)

TIPRANKS
·
03 Jun